← Feed

Taubert Jennifer L

SEC Form 4 insider
EVP, WWC. Innovative Medicine · JOHNSON & JOHNSON ($JNJ)
1 thesis · first seen Aug 18, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$JNJSEC Form 4bearish
Taubert Jennifer L · EVP, WWC. Innovative Medicine at JOHNSON & JOHNSON · 4h agono track record yet
Sold 15,000 @ $263.36 avg · $3,950,400 · 2026-08-17

Form 4: Taubert Jennifer L sold JNJ

Taubert Jennifer L (EVP, WWC. Innovative Medicine at JOHNSON & JOHNSON) reported an open-market sale of 15,000 shares of JNJ at an average $263.36, roughly $3,950,400, in a Form 4 filed 2026-08-18.

View filing on SEC.gov →

End of results.